Well Told Grants

Federal grant recipients / North Carolina

Federal grants to Baebies, Inc.

Durham, North Carolina · Small businesses · UEI NZSZBQ9B84T1

Baebies, Inc. in Durham, North Carolina received $14.5 million in federal grants from fiscal 2021 to 2025, across 11 awards. Its largest program was Cardiovascular Diseases Research, with $9.4 million. In fiscal 2025 it was awarded $2.3 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Baebies, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20217$6.2 million
FY 20227$3.1 million
FY 20233$1.7 million
FY 20242$1.2 million
FY 20252$2.3 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Baebies, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Cardiovascular Diseases Research 93.8375$9.4 million
Allergy and Infectious Diseases Research 93.8552$2.8 million
Child Health and Human Development Extramural Research 93.8653$1.7 million
Drug Use and Addiction Research Programs 93.2791$564,449

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services11$14.5 million

Largest awards

The 10 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Improving anticoagulation monitoring in pediatric patients: use of a microfluidic platform to test low volume blood samples obtained by heel-stick collection
ASST_NON_R44HL140662_075 on USAspending
Cardiovascular Diseases ResearchApril 30, 2021$2.9 million
A near-patient, low blood volume platform for rapid comprehensive evaluation of coagulation in trauma patients - abstract a near-patient, low blood volume platform for rapid comprehensive evaluation of coagulation in trauma patients (fast-track sbir) trauma is a leading cause of death worldwide, wit
ASST_NON_R44HL169045_075 on USAspending
Cardiovascular Diseases ResearchApril 6, 2023$2.3 million
A low blood volume platform for recurrent anticoagulation and kidney monitoring during continuous renal replacement therapy in critically ill children - abstract a low blood volume platform for recurrent anticoagulation and kidney monitoring during continuous renal replacement therapy in critically
ASST_NON_R44HL162151_075 on USAspending
Cardiovascular Diseases ResearchMay 23, 2022$2.0 million
Digital microfluidics - minimizing blood volume for pediatric coagulation screening
ASST_NON_R44HL125484_075 on USAspending
Cardiovascular Diseases ResearchMarch 23, 2021$1.7 million
Rapid differential diagnosis of COVID-19 and common respiratory infections - abstract rapid differential diagnosis of COVID-19 and common respiratory infections fast track sbir NOT-AI-20-031 the ongoing novel coronavirus disease (COVID-19) pandemic is spreading rapidly across the globe with over 3.2
ASST_NON_R44AI157716_075 on USAspending
Allergy and Infectious Diseases ResearchFebruary 11, 2021$1.5 million
Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses
ASST_NON_R44HD102242_075 on USAspending
Child Health and Human Development Extramural ResearchSeptember 15, 2021$1.3 million
A rapid, point-of-care diagnostic to identify viable sexually transmitted infections, reduce overtreatment, and prevent emerging antibiotic resistance - abstract a rapid, point-of-care diagnostic to identify viable sexually transmitted infections, reduce overtreatment, and prevent emerging antibioti
ASST_NON_R44AI188680_075 on USAspending
Allergy and Infectious Diseases ResearchDecember 17, 2024$1.3 million
Feasibility and validation of an integrated newborn screening algorithm with targeted next generation sequencing (TNGS) technology as part of a 2ND-TIER test for pompe and mps i
ASST_NON_R44HD094543_075 on USAspending
Child Health and Human Development Extramural ResearchDecember 18, 2020$690,191
A novel workflow to screen for illicit drug exposure in newborns
ASST_NON_R44DA050375_075 on USAspending
Drug Use and Addiction Research ProgramsJune 17, 2021$564,449
An innovative unbound bilirubin assay to identify bilirubin-induced neurological dysfunction (BIND) risk as part of a comprehensive and novel point-of-care newborn screening panel
ASST_NON_R44HL146016_075 on USAspending
Cardiovascular Diseases ResearchDecember 18, 2020$506,911

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Baebies, Inc. get?

$14.5 million in 11 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Baebies, Inc. the most?

The Department of Health and Human Services, with $14.5 million in 11 awards.

What is Baebies, Inc.'s largest federal grant?

$2.9 million under Cardiovascular Diseases Research, with its first action in the period on April 30, 2021. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Baebies, Inc.?

Its largest are Cardiovascular Diseases Research, Allergy and Infectious Diseases Research and Child Health and Human Development Extramural Research.

Other grant recipients in Durham

Largest federal grant recipients in North Carolina · Federal grants in North Carolina